mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.098 |
0.5 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |